PubRank

David J Sugarbaker

Author PubWeight™ 161.29‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer. Clin Cancer Res 2008 9.29
2 Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 2009 7.07
3 Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 2008 6.64
4 The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups. J Thorac Cardiovasc Surg 2012 4.68
5 Video-assisted thoracic surgery lobectomy: report of CALGB 39802--a prospective, multi-institution feasibility study. J Clin Oncol 2007 4.42
6 Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma. Int J Radiat Oncol Biol Phys 2006 4.22
7 Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res 2002 3.90
8 Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest 2005 3.55
9 Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemia. Cancer Res 2004 3.20
10 Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res 2002 2.48
11 Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 2009 2.26
12 Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest 2005 1.89
13 Management of High-Throughput DNA Sequencing Projects: Alpheus. J Comput Sci Syst Biol 2008 1.85
14 Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg 2004 1.82
15 Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer. Ann Thorac Surg 2006 1.79
16 Modified T-tube repair of delayed esophageal perforation results in a low mortality rate similar to that seen with acute perforations. Ann Thorac Surg 2007 1.78
17 Nodal downstaging predicts survival following induction chemotherapy for stage IIIA (N2) non-small cell lung cancer in CALGB protocol #8935. J Surg Oncol 2006 1.75
18 Epigenetic profiles distinguish pleural mesothelioma from normal pleura and predict lung asbestos burden and clinical outcome. Cancer Res 2009 1.73
19 Non-small cell lung cancer clinical practice guidelines in oncology. J Natl Compr Canc Netw 2006 1.68
20 Minimally invasive esophagectomy: results of a prospective phase II multicenter trial-the eastern cooperative oncology group (E2202) study. Ann Surg 2015 1.67
21 Factors predicting poor survival after resection of stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 2007 1.66
22 Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics 2010 1.63
23 Functional analysis of c-Met/hepatocyte growth factor pathway in malignant pleural mesothelioma. Cancer Res 2006 1.61
24 Identification of novel candidate oncogenes and tumor suppressors in malignant pleural mesothelioma using large-scale transcriptional profiling. Am J Pathol 2005 1.60
25 Using gene expression ratios to predict outcome among patients with mesothelioma. J Natl Cancer Inst 2003 1.59
26 Menopausal effects on presentation, treatment, and survival of women with non-small cell lung cancer. Ann Thorac Surg 2003 1.56
27 Postoperative antibacterial prophylaxis for the prevention of infectious complications associated with tube thoracostomy in patients undergoing elective general thoracic surgery: a double-blind, placebo-controlled, randomized trial. JAMA Surg 2013 1.47
28 High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation. J Clin Oncol 2005 1.44
29 Cardiac decortication (epicardiectomy) for occult constrictive cardiac physiology after left extrapleural pneumonectomy. Chest 2002 1.40
30 Incidence of atrial fibrillation after extrapleural pneumonectomy vs. pleurectomy in patients with malignant pleural mesothelioma. Interact Cardiovasc Thorac Surg 2008 1.39
31 Induction docetaxel and carboplatin followed by weekly docetaxel and carboplatin with concurrent radiotherapy, then surgery in stage III non-small cell lung cancer: a Phase I study. Clin Cancer Res 2003 1.38
32 Lobectomy versus sublobar resection for small (2 cm or less) non-small cell lung cancers. Ann Thorac Surg 2011 1.34
33 Relationship between a history of antecedent cancer and the probability of malignancy for a solitary pulmonary nodule. Chest 2004 1.34
34 Laparoscopic fundoplication in patients with end-stage lung disease awaiting transplantation. J Thorac Cardiovasc Surg 2006 1.32
35 The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass. J Thorac Cardiovasc Surg 2013 1.31
36 Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 2009 1.25
37 Examination of a CpG island methylator phenotype and implications of methylation profiles in solid tumors. Cancer Res 2006 1.23
38 Phase I to II study of pleurectomy/decortication and intraoperative intracavitary hyperthermic cisplatin lavage for mesothelioma. J Clin Oncol 2006 1.23
39 A prognostic test for adenocarcinoma of the lung from gene expression profiling data. Cancer Epidemiol Biomarkers Prev 2003 1.22
40 Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage. Chest 2005 1.14
41 Asbestos exposure predicts cell cycle control gene promoter methylation in pleural mesothelioma. Carcinogenesis 2008 1.14
42 Inhibitor of apoptosis protein-1 promotes tumor cell survival in mesothelioma. Carcinogenesis 2002 1.14
43 The MARS feasibility trial: conclusions not supported by data. Lancet Oncol 2011 1.13
44 Differentiation of lung adenocarcinoma, pleural mesothelioma, and nonmalignant pulmonary tissues using DNA methylation profiles. Cancer Res 2009 1.12
45 Second generation sequencing of the mesothelioma tumor genome. PLoS One 2010 1.12
46 Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance. J Thorac Cardiovasc Surg 2012 1.11
47 Lung resection in patients with preoperative FEV1 < 35% predicted. Chest 2005 1.11
48 Frequent HIN-1 promoter methylation and lack of expression in multiple human tumor types. Mol Cancer Res 2004 1.10
49 Validation of genomics-based prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 2005 1.09
50 Downregulated microRNAs in the differential diagnosis of malignant pleural mesothelioma. Int J Cancer 2010 1.09
51 Immunohistochemical markers associated with brain metastases in patients with nonsmall cell lung carcinoma. Cancer 2008 1.07
52 Four-gene expression ratio test for survival in patients undergoing surgery for mesothelioma. J Natl Cancer Inst 2009 1.06
53 Circulating and tumor-infiltrating myeloid cells predict survival in human pleural mesothelioma. Cancer 2011 1.06
54 The use of cardiopulmonary bypass during resection of locally advanced thoracic malignancies: a 10-year two-center experience. Chest 2004 1.05
55 Benign emptying of the postpneumonectomy space. Ann Thorac Surg 2011 1.02
56 Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume. AJR Am J Roentgenol 2012 1.01
57 Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma. Cancer Chemother Pharmacol 2007 1.01
58 mTOR mediates survival signals in malignant mesothelioma grown as tumor fragment spheroids. Am J Respir Cell Mol Biol 2008 1.01
59 Surgery for early stage non-small cell lung cancer. Semin Surg Oncol 2003 1.01
60 Percutaneous treatment of high-output chylothorax with embolization or needle disruption technique. J Vasc Interv Radiol 2005 1.00
61 FDG PET/CT patterns of treatment failure of malignant pleural mesothelioma: relationship to histologic type, treatment algorithm, and survival. Eur J Nucl Med Mol Imaging 2011 0.99
62 Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma. Neoplasia 2011 0.98
63 Effusive-constrictive pericarditis. N Engl J Med 2004 0.98
64 Radiofrequency ablation of thoracic lesions: part 2, initial clinical experience--technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 2005 0.97
65 Vorinostat eliminates multicellular resistance of mesothelioma 3D spheroids via restoration of Noxa expression. PLoS One 2012 0.95
66 Asbestos burden predicts survival in pleural mesothelioma. Environ Health Perspect 2008 0.94
67 Morphologic and functional imaging of malignant pleural mesothelioma. Eur J Radiol 2007 0.94
68 A phase I study of extrapleural pneumonectomy and intracavitary intraoperative hyperthermic cisplatin with amifostine cytoprotection for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2009 0.94
69 Surgical interventions for emphysema. Semin Thorac Cardiovasc Surg 2007 0.93
70 Repeated and aggressive pulmonary resections for leiomyosarcoma metastases extends survival. Ann Thorac Surg 2011 0.93
71 Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol 2002 0.93
72 Hyperthermic chemoperfusion for the treatment of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2008 0.93
73 Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. AJR Am J Roentgenol 2010 0.93
74 Fine-needle aspiration biopsies for gene expression ratio-based diagnostic and prognostic tests in malignant pleural mesothelioma. Clin Cancer Res 2010 0.92
75 Primary Ewing sarcoma invading the heart: resection and reconstruction. J Thorac Cardiovasc Surg 2007 0.92
76 Extrapleural pneumonectomy for diffuse malignant pleural mesothelioma: techniques and complications. Thorac Surg Clin 2004 0.91
77 Pleural biopsy: a reliable method for determining the diagnosis but not subtype in mesothelioma. Ann Thorac Surg 2004 0.90
78 Proposed adjustments to pathologic staging of epithelial malignant pleural mesothelioma based on analysis of 354 cases. Cancer 2010 0.90
79 Activation of focal adhesion kinase in human lung cancer cells involves multiple and potentially parallel signaling events. J Cell Mol Med 2005 0.90
80 Integrated profiling reveals a global correlation between epigenetic and genetic alterations in mesothelioma. Cancer Res 2010 0.89
81 Expression of interleukin-4 receptor alpha in human pleural mesothelioma is associated with poor survival and promotion of tumor inflammation. Clin Cancer Res 2012 0.89
82 Radiotherapy versus chemotherapy plus radiotherapy in surgically treated IIIA N2 non-small-cell lung cancer. Clin Lung Cancer 2002 0.88
83 Outcomes of patients with stage III nonsmall cell lung cancer treated with chemotherapy and radiation with and without surgery. Cancer 2009 0.87
84 Integrin-dependent protein tyrosine phosphorylation is a key regulatory event in collagen-IV-mediated adhesion and proliferation of human lung tumor cell line, Calu-1. Ann Thorac Surg 2004 0.87
85 Prospective phase II trial of preresection thoracoscopic mediastinal restaging after neoadjuvant therapy for IIIA (N2) non-small cell lung cancer: results of CALGB Protocol 39803. J Thorac Cardiovasc Surg 2013 0.86
86 Characteristics of malignant pleural mesothelioma in women. Ann Thorac Surg 2010 0.86
87 Prevalence of in vitro chemotherapeutic drug resistance in primary malignant pleural mesothelioma: result in a cohort of 203 resection specimens. J Thorac Cardiovasc Surg 2010 0.85
88 The immunohistochemical characterization of sarcomatoid malignant mesothelioma of the pleura. Am J Cancer Res 2010 0.85
89 Current trends in radiologic management of malignant pleural mesothelioma. Semin Thorac Cardiovasc Surg 2009 0.85
90 Genes associated with prognosis after surgery for malignant pleural mesothelioma promote tumor cell survival in vitro. BMC Cancer 2011 0.85
91 Patterns of allelic loss differ in lung adenocarcinomas of smokers and nonsmokers. Lung Cancer 2003 0.84
92 Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. Cancer 2008 0.84
93 Complications of extrapleural pneumonectomy. Semin Thorac Cardiovasc Surg 2007 0.84
94 Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication. Semin Thorac Cardiovasc Surg 2009 0.84
95 Clinicopathologic characteristics of malignant mesotheliomas arising in patients with a history of radiation for Hodgkin and non-Hodgkin lymphoma. J Clin Oncol 2013 0.84
96 Extrapleural pneumonectomy for malignant pleural mesothelioma. Multimed Man Cardiothorac Surg 2005 0.84
97 Impact of nonrigid motion correction technique on pixel-wise pharmacokinetic analysis of free-breathing pulmonary dynamic contrast-enhanced MR imaging. J Magn Reson Imaging 2011 0.84
98 Innovative therapies: intraoperative intracavitary chemotherapy. Thorac Surg Clin 2004 0.83
99 Assessment of malignant pleural mesothelioma with (18)F-FDG dual-head gamma-camera coincidence imaging: comparison with histopathology. J Nucl Med 2002 0.83
100 Morbidity of lung resection after prior lobectomy: results from the Veterans Affairs National Surgical Quality Improvement Program. Ann Thorac Surg 2007 0.82
101 Influence of radiotherapy technique and dose on patterns of failure for mesothelioma patients after extrapleural pneumonectomy. Int J Radiat Oncol Biol Phys 2007 0.82
102 Section V: techniques of esophageal resection. Semin Thorac Cardiovasc Surg 2003 0.81
103 Differentially expressed alternatively spliced genes in malignant pleural mesothelioma identified using massively parallel transcriptome sequencing. BMC Med Genet 2009 0.81
104 Non-small cell lung cancer. J Natl Compr Canc Netw 2008 0.81
105 Multimodality management of malignant pleural mesothelioma: introduction. Semin Thorac Cardiovasc Surg 2009 0.80
106 VATS pericardiotomy for patients with known malignancy and pericardial effusion: survival and prognosis of positive cytology and metastatic involvement of the pericardium: a case control study. Int J Surg 2008 0.80
107 Cardiac sarcoma 14 years after treatment for pleural mesothelioma. N Engl J Med 2005 0.80
108 The relationship between tumor MSLN methylation and serum mesothelin (SMRP) in mesothelioma. Epigenetics 2011 0.79
109 Diffuse malignant mesothelioma of the pleural space and its management. Oncology (Williston Park) 2002 0.79
110 Malignant pleural mesothelioma: overview of the North American and European experience. Thorac Surg Clin 2004 0.79
111 Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma. Int J Surg 2008 0.79
112 Current surgical management of malignant pleural mesothelioma. Curr Oncol Rep 2002 0.78
113 Clinical application of pharmacokinetic analysis as a biomarker of solitary pulmonary nodules: dynamic contrast-enhanced MR imaging. Magn Reson Med 2012 0.77
114 Utility of Adjuvant Chemotherapy After Neoadjuvant Chemoradiation and Esophagectomy for Esophageal Cancer. Ann Surg 2017 0.77
115 Vitamin D-mediated hypercalcemia and Cushing syndrome as manifestations of malignant pleural mesothelioma. Endocr Pract 2008 0.77
116 Detection and quantification of SV40 large T-antigen DNA in mesothelioma tissues and cell lines. Oncol Rep 2002 0.77
117 MR imaging of benign and malignant pleural disease. Magn Reson Imaging Clin N Am 2008 0.76
118 Safety and efficacy of radiation dose delivered via iodine-125 brachytherapy mesh implantation for deep cavity sarcomas. Ann Surg Oncol 2014 0.76
119 Managing the pneumonectomy space after extrapleural pneumonectomy: postoperative intrathoracic pressure monitoring. Eur J Cardiothorac Surg 2010 0.75
120 Use of postoperative creatinine to predict sustained kidney injury in patients undergoing mesothelioma surgery. Clin J Am Soc Nephrol 2012 0.75
121 Severe toxicity after permanent radioactive seed implantation for mediastinal carcinoid tumors. Brachytherapy 2006 0.75
122 A microthymoma and no germinal centre in myasthenia gravis. Eur J Cardiothorac Surg 2013 0.75
123 Interatrial shunting after major thoracic surgery: a rare but clinically significant event. Ann Thorac Surg 2012 0.75
124 Clinical indications and results after chest wall resection for recurrent mesothelioma. J Thorac Cardiovasc Surg 2013 0.75
125 Unusual case of hemoptysis 13 years after bilobectomy. Ann Thorac Surg 2007 0.75